1. Should Niacin Be the Preferred Drug to Add to a Statin?

   • Michael H. Davidson

   Clinical trial report 07 September 2010 Pages: 447 - 449

2. Have the Renin-Angiotensin-Aldosterone System Perturbations in Cardiovascular Disease Been Exhausted?

   • Sulaf J. Mansur
   • Fadi G. Hage
   • Suzanne Oparil

   ReviewPaper 09 September 2010 Pages: 450 - 463

   

3. The Role of Renin-Angiotensin Agents in Altering the Natural History of Type 2 Diabetes Mellitus

   • Joel A. Lardizabal
   • Prakash C. Deedwania

   ReviewPaper Open access 01 September 2010 Pages: 464 - 471

   

4. Advances in Pharmacologic Modulation of Nitric Oxide in Hypertension

   • Yoshiko Mizuno
   • Robert F. Jacob
   • R. Preston Mason

   ReviewPaper 01 September 2010 Pages: 472 - 480

   

5. Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease

   • Peter P. Toth

   ReviewPaper 26 August 2010 Pages: 481 - 487

   

6. Recognizing and Improving Health Care Disparities in the Prevention of Cardiovascular Disease in Women

   • Jennifer L. Jarvie
   • JoAnne M. Foody

   ReviewPaper 24 August 2010 Pages: 488 - 496

   

7. New Advances in Noninvasive Imaging of the Carotid Artery: CIMT, Contrast-Enhanced Ultrasound, and Vasa Vasorum

   • Blai Coll
   • Vijay Nambi
   • Steven B. Feinstein

   ReviewPaper 27 August 2010 Pages: 497 - 502

8. The Omega-3 Index: Clinical Utility for Therapeutic Intervention

   • William S. Harris

   ReviewPaper 01 September 2010 Pages: 503 - 508